The Hidden Oncology Gatekeepers Shaping Access to Life-Saving Cancer Therapies

Political debates over cancer drug prices often miss the hidden specialty pharmacy gatekeepers that dictate whether patients actually receive life-saving treatments.

“The future of oncology will undoubtedly include more sophisticated therapies, more personalized treatment strategies, and continued scientific breakthroughs,” writes SHARx Chief Growth Officer Paul Pruitt. “What remains uncertain is whether the systems surrounding those therapies will evolve at the same pace.”